Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK.LN | ||||
| Company | Gsk Plc | ||||
| Price Information | |||||
| Exchange | LSE | ||||
| Open | 2,050.000 | ||||
| High | 2,051.000 | ||||
| Low | 1,850.500 | ||||
| Latest | 1,918.000 | ||||
| Change | -110.000 | ||||
| % Change | -5.42% | ||||
| Volume | 14,648,684 | ||||
| 20-Day Average Volume | 7,981,730 | ||||
| Previous Close | 2,028.000 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 2,099.450 | ||||
| 20-Day Raw Stochastic | 19.20% | ||||
| 20-Day Relative Strength | 35.61 | ||||
| Weighted Alpha | +28.78 | ||||
| Today's Opinion | 40% Buy | ||||
| Previous Opinion | 64% Buy | ||||
| Last Month's Opinion | 72% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.57% since 04/22/26 | ||||
| Low | 1,850.500 on 04/29/26 | ||||
| High | 2,083.000 on 04/23/26 | ||||
| 1-Month | |||||
| %Chg | -6.39% since 03/27/26 | ||||
| Low | 1,850.500 on 04/29/26 | ||||
| High | 2,202.000 on 04/15/26 | ||||
| 3-Month | |||||
| %Chg | +3.56% since 01/29/26 | ||||
| Low | 1,823.000 on 01/30/26 | ||||
| High | 2,282.000 on 02/18/26 | ||||
| 6-Month | |||||
| %Chg | +9.47% since 10/29/25 | ||||
| Low | 1,722.500 on 10/30/25 | ||||
| High | 2,282.000 on 02/18/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 80,956,655 | ||||
| Shares Outstanding, K | 3,996,847 | ||||
| Annual Sales | 32,667,000,000 | ||||
| Annual Net Income | 5,716,000,000 | ||||
| Last Quarter Sales | 8,618,000,000 | ||||
| Last Quarter Net Income | 636,000,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | 0.16 on 02/04/26 | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | 0.180 on 02/19/26 | ||||
| Next Ex-Dividends Date | 02/19/26 | ||||
| Ratios | |||||
| Price/Earnings ttm | 14.61 | ||||